Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» Business development
Business development
Latest News
2024 Annual Report
November 18, 2024
2024 BioDiem AnnualReport
Read More
Notice of Annual General Meeting and Proxy Form
November 8, 2024
View the Notice of Annual General Meeting and Proxy Form
Read More
